Table 3.
Representative literature review of distal femoral oncologic endoprosthetic survivorship
| Study | Number of patients available for review | Stated implant type | Survival (%) | Aseptic failure (%) | Septic failure (%) | Failure due to local recurrence (%) | ||
|---|---|---|---|---|---|---|---|---|
| 5-year | 10-year | 20-year | ||||||
| Unwin et al. [27] | 493 | CIS | 90.1 | 67.4 | 9.1 | 1.8 | 6.5 | |
| Meyers et al. [19] | 335 | CIS | 61.0 | 23.6 | 9.6 | 6.0 | ||
| Jeys et al. [13] | 228 | CIS | 52.7 | 30.5 | 13.6 | 12.7 | 5.3 | |
| Schwartz et al. [24] | 186 | CIS | 77.0 | 58.0 | 11.8 | 3.7 | ||
| Roberts et al. [22] | 135 | CIS | 75.0 | |||||
| Bickels et al. [4] | 110 | CIS | 93.0 | 88.0 | 5.4 | 4.5 | ||
| Gosherger et al. [8] | 103 | CIS/UIS | 65.9 | 14.6 | 11.7 | |||
| Ahlmann et al. [1] | 78 | CIS | 75.0 | 58.0 | 5.1 | 6.4 | 2.6 | |
| Torbert et al. [25] | 57 | CIS | 84.0 | 66.0 | ||||
| Farfalli et al. [7] | 50 | UIS | 85.0 | 71.0 | 24.0 | |||
| Farfalli et al. [7] | 41 | CPS | 88.0 | |||||
| Current study | 26 | CIS | 66.6 | 7.7 | 11.5 | 7.7 | ||
| Current study | 26 | CPS | 83.5 | 3.8 | 11.5 | |||
CPS = Compress® Compliant Pre-Stress Implant; CIS = cemented intramedullary stem; UIS = uncemented intramedullary stem.